CoChat

Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis

Open access
Sun, Da-Li, Cen, Yun-Yun, Li, Shu-Min, Li, Wei-Ming, Lu, Qi-Ping, Xu, Peng-Yuan · 2016 · Scientific Reports
Cited by 88

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Numerous studies have investigated the utility of serum intestinal fatty-acid binding protein (I-FABP) in differentiating acute intestinal ischemia from acute abdomen. However, the results remain controversial. The aim of this meta-analysis is to determine the overall accuracy of serum I-FABP in the diagnosis of acute intestinal ischemia. Publications addressing the accuracy of serum I-FABP in the diagnosis of ischemic bowel diseases were selected from databases. The values of true-positive (TP), true-negative (TN), false-positive (FP) and false-negative (FN) were extracted or calculated for each study. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratio (DOR) were calculated. The overall diagnostic performance was assessed using a summary receiver operating characteristic curve (SROC) and area under curve (AUC). Nine studies that collectively included 1246 patients met the eligible criteria. The pooled sensitivity, specificity, DOR, PLR and NLR were 0.80 (95% CI: 0.72–0.86), 0.85 (95% CI: 0.73–0.93), 24 (95% CI: 9–65), 5.5 (95% CI: 2.8–10.8) and 0.23 (95% CI: 0.15–0.35), respectively. The AUC was 0.86 (95% CI: 0.83–0.89). The meta-analysis carried out in this report suggests that the I-FABP may be a useful diagnostic tool to confirm acute intestinal ischemia in acute abdomen, but better-designed trials are still required to confirm our findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep34371

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 30

  1. Furukawa, A. et al. CT diagnosis of acute mesenteric ischemia from various causes. AJR Am J Roentgenol 192, 408–416 (2009). · DOI · Paper page
  2. Angelelli, G. et al. Acute bowel ischemia: CT findings. Eur J Radiol 50, 37–47 (2004). · DOI
  3. Kozuch, P. L. et al. Review article: diagnosis and management of mesenteric ischemia with an emphasis on pharmacotherapy. Aliment Pharmacol Ther 21, 201–215 (2005). · DOI · Paper page
  4. Crenn, P. et al. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 27, 328–339 (2008). · DOI · Paper page
  5. Cakmaz, R. et al. A combination of plasma DAO and citrulline levels as a potential marker for acute mesenteric ischemia. Libyan J Med 8, 1–6 (2013). · DOI
  6. Pelsers, M. M. et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 36, 529–535 (2003). · DOI · Paper page
  7. Shi, H. et al. The role of serum intestinal fatty acid binding protein levels and D-lactate levels in the diagnosis of acute intestinal ischemia. Clin Res Hepatol Gastroenterol 39, 373–378 (2015). · DOI
  8. Kanda, T. et al. Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol 46, 492–500 (2011). · DOI
  9. Kittaka, H. et al. Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. PLoS One 13, e99915 (2014). · DOI · Paper page
  10. Jin, H. Value of intestinal fatty acid binding protein in diagnose of ischemic bowel disease. Chin J Immuno (Chinese) 30, 531–533 (2014).
  11. Cronk, D. R. et al. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg 63, 322–325 (2006). · DOI
  12. Shi, H. et al. The value of serum intestinal fatty acid blinding protein measurement in discriminating intestinal ischemia in patients with acute abdomen. Chin J Intern Med (Chinese) 51, 690–693 (2012).
  13. Vermeulen Windsant, I. C. et al. Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg 255, 796–803 (2012). · DOI · Paper page
  14. van der Voort, P. H. et al. Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia. BMC Anesthesiol 14, 111 (2014). · DOI · Paper page
  15. Leeflang, M. M. et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med 149, 889–897 (2008). · DOI · Paper page
  16. Jones, C. M. et al. Diagnostic accuracy meta-analysis: a review of the basic principles of interpretation and application. Int J Cardiol 140, 138–144 (2010). · DOI
  17. Higgins, J. P. et al. Measuring inconsistency in meta-analyses. BMJ 327, 557–560 (2003). · DOI · Paper page
  18. Kanda, T. et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110, 339–343 (1996). · DOI · Paper page
  19. Hu, K. Q. et al. Change of plasma intestinal fatty acid-binding protein and liver fatty acid-binding protein in children with intestinal ischemia. J Clin Pedia Surg (Chinese) 9, 95–97 (2010).
  20. Hu, K. Q. et al. The value of serum intestinal fatty acid blinding protein measurement in discriminating intestinal ischemia in children. Shanxi Med J (Chinese) 39, 418–419 (2010).
  21. Yan, W. L. et al. Diagnostic value of plasma intestinal fatty acid-binding protein and creatine kinase in patients subjected with intestinal obstruction. Zhongguo Zhong Xi Yi Jie He Za Zhi (Chinese) 19, 624–626 (2013).
  22. Li, L. & Liang, H. F. Application of IFABP, LFABP detection technology in children with intestinal ischemia. Chin J Pharma Econom (Chinese) 1, 64–66 (2012).
  23. Jin, H. The relationship between intestinal fatty acid binding protein and the severity and prognosis of ischemic bowel disease. Zhe Jiang Lin Chuang Yi Xue (Chinese) 16, 371–372 (2014).
  24. Shen, D. H. et al. The value of serum intestinal fatty acid blinding protein in intestinal diseases. Shi Yong Yi Xue Za Zhi (Chinese) 21, 2535–2536 (2005).
  25. van Noord, D. et al. Serum markers and intestinal mucosal injury in chronic gastrointestinal ischemia. Dig Dis Sci 56, 506–512 (2011). · DOI
  26. Wang, H. et al. The diagnosis value of combination of I-FABP, D-LAC, Fg in acute ischemic enteritis. Lin Chuang He Li Yong Yao (Chinese) 7, 144–145 (2014).
  27. Zheng, L. et al. The value of I-FABP measurement in the diagnosis of intestinal ischemic in patients with acute intestinal obstruction. Int J Lab Med (Chinese) 35, 410–411 (2014).
  28. Wang, H. et al. The diagnosing value of I-FABP, D-LAC in ischemic enteritis. Lin Chuang He Li Yong Yao (Chinese) 7, 112–114 (2014).
  29. Riffelmann, M. et al. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 48, 4459–4463 (2010). · doi:10.1128/jcm.01371-10
  30. van de Wouw, B. A. et al. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependentdiagnosis for detecting Helicobacter pylori infection. J Clin Microbiol 34(1), 94–97 (1996). · doi:10.1128/jcm.34.1.94-97.1996

Cited by

See all 88

Metadata

Authors
Sun, D.-L., Cen, Y.-Y., Li, S.-M., Li, W.-M., Lu, Q.-P., & Xu, P.-Y.
Venue
Scientific Reports
Published
2016-09-29
Volume
6
Issue
1
Pages
34371-34371
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2525164642
Cited by
88
References
9
FWCI
1.74
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.